Literature DB >> 26034331

Scalable syntheses of the BET bromodomain inhibitor JQ1.

Shameem Sultana Syeda1, Sudhakar Jakkaraj1, Gunda I Georg1.   

Abstract

We have developed methods involving the use of alternate, safer reagents for the scalable syntheses of the potent BET bromodomain inhibitor JQ1. A one-pot three step method, involving the conversion of a benzodiazepine to a thioamde using Lawesson's reagent, followed by amidrazone formation and installation of the triazole moiety furnished JQ1. This method provides good yields and a facile purification process. For the synthesis of enantiomerically enriched (+)-JQ1, the highly toxic reagent diethyl chlorophosphate, used in a previous synthesis, was replaced with the safer reagent diphenyl chlorophosphate in the three-step one-pot triazole formation without effecting yields and enantiomeric purity of (+)-JQ1.

Entities:  

Keywords:  BET inhibitors; Bromodomains; Male contraceptive; One-pot method; Thionation; Triazolothienodiazepine (+)-JQ1

Year:  2015        PMID: 26034331      PMCID: PMC4448696          DOI: 10.1016/j.tetlet.2015.02.062

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  12 in total

1.  Structure and function of a human TAFII250 double bromodomain module.

Authors:  R H Jacobson; A G Ladurner; D S King; R Tjian
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

2.  The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins.

Authors:  S R Haynes; C Dollard; F Winston; S Beck; J Trowsdale; I B Dawid
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

3.  Preparation of small-molecule microarrays by trans-cyclooctene tetrazine ligation and their application in the high-throughput screening of protein-protein interaction inhibitors of bromodomains.

Authors:  Chong-Jing Zhang; Chelsea Y J Tan; Jingyan Ge; Zhenkun Na; Grace Y J Chen; Mahesh Uttamchandani; Hongyan Sun; Shao Q Yao
Journal:  Angew Chem Int Ed Engl       Date:  2013-11-04       Impact factor: 15.336

4.  Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.

Authors:  Olivier Mirguet; Romain Gosmini; Jérôme Toum; Catherine A Clément; Mélanie Barnathan; Jean-Marie Brusq; Jacqueline E Mordaunt; Richard M Grimes; Miriam Crowe; Olivier Pineau; Myriam Ajakane; Alain Daugan; Phillip Jeffrey; Leanne Cutler; Andrea C Haynes; Nicholas N Smithers; Chun-wa Chung; Paul Bamborough; Iain J Uings; Antonia Lewis; Jason Witherington; Nigel Parr; Rab K Prinjha; Edwige Nicodème
Journal:  J Med Chem       Date:  2013-09-25       Impact factor: 7.446

5.  BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

Authors:  Jake E Delmore; Ghayas C Issa; Madeleine E Lemieux; Peter B Rahl; Junwei Shi; Hannah M Jacobs; Efstathios Kastritis; Timothy Gilpatrick; Ronald M Paranal; Jun Qi; Marta Chesi; Anna C Schinzel; Michael R McKeown; Timothy P Heffernan; Christopher R Vakoc; P Leif Bergsagel; Irene M Ghobrial; Paul G Richardson; Richard A Young; William C Hahn; Kenneth C Anderson; Andrew L Kung; James E Bradner; Constantine S Mitsiades
Journal:  Cell       Date:  2011-09-01       Impact factor: 41.582

Review 6.  Targeting bromodomains: epigenetic readers of lysine acetylation.

Authors:  Panagis Filippakopoulos; Stefan Knapp
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

Review 7.  Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.

Authors:  Michelle R Arkin; Yinyan Tang; James A Wells
Journal:  Chem Biol       Date:  2014-09-18

8.  Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.

Authors:  Mark A Dawson; Rab K Prinjha; Antje Dittmann; George Giotopoulos; Marcus Bantscheff; Wai-In Chan; Samuel C Robson; Chun-wa Chung; Carsten Hopf; Mikhail M Savitski; Carola Huthmacher; Emma Gudgin; Dave Lugo; Soren Beinke; Trevor D Chapman; Emma J Roberts; Peter E Soden; Kurt R Auger; Olivier Mirguet; Konstanze Doehner; Ruud Delwel; Alan K Burnett; Phillip Jeffrey; Gerard Drewes; Kevin Lee; Brian J P Huntly; Tony Kouzarides
Journal:  Nature       Date:  2011-10-02       Impact factor: 49.962

9.  Small-molecule inhibition of BRDT for male contraception.

Authors:  Martin M Matzuk; Michael R McKeown; Panagis Filippakopoulos; Qinglei Li; Lang Ma; Julio E Agno; Madeleine E Lemieux; Sarah Picaud; Richard N Yu; Jun Qi; Stefan Knapp; James E Bradner
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

10.  Selective inhibition of BET bromodomains.

Authors:  Panagis Filippakopoulos; Jun Qi; Sarah Picaud; Yao Shen; William B Smith; Oleg Fedorov; Elizabeth M Morse; Tracey Keates; Tyler T Hickman; Ildiko Felletar; Martin Philpott; Shonagh Munro; Michael R McKeown; Yuchuan Wang; Amanda L Christie; Nathan West; Michael J Cameron; Brian Schwartz; Tom D Heightman; Nicholas La Thangue; Christopher A French; Olaf Wiest; Andrew L Kung; Stefan Knapp; James E Bradner
Journal:  Nature       Date:  2010-09-24       Impact factor: 49.962

View more
  2 in total

1.  BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen.

Authors:  Alex M Ayoub; Laura M L Hawk; Ryan J Herzig; Jiewei Jiang; Andrea J Wisniewski; Clifford T Gee; Peiliang Zhao; Jin-Yi Zhu; Norbert Berndt; Nana K Offei-Addo; Thomas G Scott; Jun Qi; James E Bradner; Timothy R Ward; Ernst Schönbrunn; Gunda I Georg; William C K Pomerantz
Journal:  J Med Chem       Date:  2017-06-07       Impact factor: 7.446

2.  New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition.

Authors:  Matthias G J Baud; Enrique Lin-Shiao; Michael Zengerle; Cynthia Tallant; Alessio Ciulli
Journal:  J Med Chem       Date:  2015-10-01       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.